发明名称 FUSED PYRIDAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT.
摘要 <p>Fused pyridazine derivatives represented by the following general formula (I) (wherein each symbol is as defined in the description) and pharmaceutically acceptable salts thereof: (I) Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by the general formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, AlzheimeraC¦s disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV, etc.) and sensitizers and immunosuppressants in treating cancer.</p>
申请公布号 MXPA04008014(A) 申请公布日期 2004.11.26
申请号 MX2004PA08014 申请日期 2003.02.18
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 WATARU KAMOSHIMA
分类号 A61K31/501;A61K31/502;A61K31/5025;A61K31/53;A61K31/5377;A61K31/541;A61K31/542;A61K31/55;A61K31/551;A61K31/554;A61P3/10;A61P7/08;A61P9/00;A61P9/10;A61P13/12;A61P25/00;A61P27/06;A61P29/00;A61P31/12;A61P31/18;A61P37/06;A61P43/00;C07D237/26;C07D237/32;C07D401/06;C07D401/12;C07D403/06;C07D403/12;C07D405/06;C07D405/12;C07D409/12;C07D417/12;C07D471/04;C07D487/04;C07D513/04;(IPC1-7):A61K31/501;A61K31/537 主分类号 A61K31/501
代理机构 代理人
主权项
地址